Latest Suspensions News

Blue Energy is positioning its Queensland gas portfolio for potential demand from LNG exporters under proposed federal reservation rules, while seeking a farm-in partner for ATP 854. The company ended September with A$3.2 million in unaudited cash, no debt and a more cautious approach to Sapphire spending.

Galan Lithium says first lithium chloride concentrate sales from Hombre Muerto West remain on track for Q4 2026, with plant data supporting the planned product quality. Earthworks have also started to lift Phase 1 capacity to 5.2ktpa, although development spending leaves the company with a measured funding runway under its Appendix 5B calculation.

Golden Cross Resources is assessing non-binding investor and partner proposals for its Copper Hill copper-gold project, but the ASX-suspended explorer ended September with just $15,000 in cash. Planned field programs and a possible quotation reinstatement remain conditional on approvals, activity and ASX discretion.

Chimeric Therapeutics has stopped enrolment and dosing in its CHM-2101 CAR-T trial after a safety review found the highest dose unsafe. With $1.35 million in cash, suspended securities and uncertain creditor negotiations, the company is now pursuing a possible recapitalisation while preserving a preclinical CDH17 pathway.

Cobre has reported record quarterly revenue and positive EBITDA at Sierra Atacama, while taking control of the Chilean copper project and mapping a potential path to 50,000 tonnes per annum. The next test is whether higher recovery and additional feed can convert operational momentum into cash flow.

Bougainville Copper remains without production more than 37 years after Panguna operations stopped, while its independent board committee weighs the implications of a rival 25-year mining lease over EL01. Further legal advice and a December committee meeting are now the next key markers.

The Supreme Court of Western Australia has approved Evolution Mining’s scheme to acquire the Carnaby Resources shares it does not already own. The transaction is expected to become effective on 30 October, with Carnaby’s ASX delisting targeted for 11 November.

Noxopharm has halted trading in its securities while it prepares an announcement about a capital raising. The suspension is scheduled to last until the earlier of the announcement or the start of trading on 2 November 2026, unless ASX decides otherwise.

The Australian Takeovers Panel has declared unacceptable circumstances in A2MP Investments’ lapsed A$0.05-a-share takeover bid for Canyon Resources, citing inadequate disclosure, the use of confidential information and potential coercion of shareholders. Final orders remain undecided.

Pearl Gull Iron remains suspended from ASX trading while it searches for a transaction that could satisfy Listing Rule 12.1 and support reinstatement. The company ended September with A$1.405 million in cash and expects a further A$2.0 million payment in December from its Cockatoo Island sale.

Matsa Resources has reported a $39.4 million FY2026 loss, negative net assets and a $28 million operating cash outflow after Devon operated at a loss and was suspended following a contractor dispute. A $55 million AngloGold tenement sale offers a potential liquidity reset, but the annual report says material uncertainty remains over the group's ability to continue as a going concern.

EQ Resources has opened FY2027 with record revenue, EBITDA, profit and operating cashflow as tungsten production climbed 81% quarter-on-quarter. The company has also set its first full-year production, cost and capital expenditure targets, while expansion work and a Spanish regulatory issue remain key execution tests.